25th Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

8th - 9th of October 2025|MÖVENPICK HOTEL | BASEL | SWITZERLAND

Sachs Associates would like to say that we have enjoyed hosting you in person and virtually and thank those who participated in our Sachs Autumn Life Sciences Week, which incorporated the 12th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 25th Annual Biotech in Europe Forum (#Sachs_BEF). A special thank you goes to the excellent lineup of sponsors, chairs, panellists, exhibitors, and presenters who made such a broad and interesting programme possible and to those who participated in person and during the virtual week.

The Life Sciences Week has proven to be successful in supporting our community with 612 delegates from 30 countries and nearly 2300 in-person & online meetings completed.   

Publicly available recordings of the sessions and presentations that took place during the event will be added once the event portal closes (after the 7th of November) on the SachsTV YouTube channel. 

We are looking forward to welcoming you again at our future events! 

SILVER SPONSOR:

Stifel

BRONZE SPONSORS:

Lilly and Company
Merck KGaA, Darmstadt, Germany
BeOne Medicines I GmbH
Novartis Pharma AG

CONTRIBUTING SPONSORS:

Cancer Research Horizons
Novo Holdings A/S
Baker McKenzie
Covington & Burling LLP

RECEPTION SPONSOR:

Canton of Basel-Stadt

Presenting Companies Included:

Adularia AG logo
Alder Therapeutics AB logo
AM-Pharma B.V. logo
Amporin Pharmaceuticals AG logo
Arivin Therapeutics Ltd. logo
Arphamid Therapeutics SAS logo
ARTCLINE GmbH logo
BIOCELL LTD. logo
biotx.ai GmbH logo
BirchBioMed Inc. logo
Cereno Scientific AB logo
Chromos Labs logo
CIS BIOPHARMA AG logo
ClearideBio AG logo
Cue Biopharma, Inc. logo
Curlim logo
Cytora logo
DCRM Sciences, Inc. logo
Diamante Società Benefit Srl logo
FINNCURE Ltd. logo
Galimedix Therapeutics, Inc. logo
Hoba Therapeutics ApS logo
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. logo
Ipsomel Innovations logo
JLP Health GmbH logo
KHAN Technology Transfer Fund logo
Ksilink logo
LIfT BioSciences Ltd. logo
Loma Therapeutics logo
metaLead Therapeutics AG logo
Mighto Therapeutics logo
ModernVivo, Inc. logo
Nanolattix logo
Neurochlore logo
NoToVir Srl logo
Oncovita logo
Oryzon Genomics, S.A. logo
Pilatus Biosciences SA logo
SAPPIENS SAS logo
Sen-Jam Pharmaceutical logo
Senya Therapeutics logo
Serenatis Bio logo
STALICLA SA logo
Stromal Therapeutics AG logo
SWISS IMMUNE | Amedioo EDC logo
SynuCa Therapeutics logo
Teitur Trophics ApS logo
Tessara Therapeutics Pty Ltd. logo
UPyTher B.V. logo
Vandria SA logo

Exhibitors Included:

ARENSIA Exploratory Medicine logo
GETEC PARK.SWISS AG logo
InvestHK logo

Confirmed Keynote Speakers Included:

Björn Cochlovius
CEO, eleva GmbH
Giancarlo Benelli
SVP, Head of Europe, BeOne Medicines I GmbH
Jan-Philipp Kruse
Senior Director, Lilly Ventures, Eli Lilly and Company
Kaspar Sutter
State Councillor, Department of Economic, Social & Environmental Affairs, Canton of Basel-Stadt
Verena Stocker
Regional Head of Gateway Labs - Europe, Eli Lilly and Company

Speakers and Chairs Included:

Andreas Wallnoefer
Managing Director, ClavystBio
Corinne Venot
VP, Global Business Development, BeOne Medicines I GmbH
Elena Startseva
Global Clinical Development Lead, Boehringer Ingelheim International GmbH
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Henrik Sindal Jensen
Senior Director of BD & Licensing, H. Lundbeck A/S
Hugh Nuthall
Executive Director, Search & Evaluation Neuroscience, Eli Lilly and Company
Julia Braun
Partner, Baker McKenzie
Kelly Curtin
Managing Director, Stifel
Mads Peter Hemmingsen
Venture Partner, Novo Holdings A/S
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Stefan Luzi
Partner, Gilde Healthcare Partners B.V.
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Vanessa King
CEO, King Bioventures
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Ximing Ding
Principal, Pureos Bioventures
Ajla Hrle
CBO, Disco Pharmaceuticals GmbH
Alex Blyth
CEO, LIfT BioSciences Ltd.
Allan Marchington
Managing Director, Head of Life Sciences, Intermediate Capital Group PLC
Anna Jen Beuchat
Director Business Development, F. Hoffmann-La Roche AG
Anu Balendran
Head BD&L Transactions, CRM, Novartis Pharma AG
Asun Monfort
Investment Advisor, HBM Partners AG
Björn Cochlovius
CEO, eleva GmbH
Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.
Christoph Schäfer
CEO, CIS BIOPHARMA AG
Cindy Daniel
Head of Unit - Life Sciences & Healthcare - Equity Investments, European Investment Fund
Clément Bertholet
Managing Partner, AdBio Partners
Colette Lipp
Senior Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
Craig Fox
Operating Partner, Oxford Science Enterprises
Daniel Rankin
SVP, Head of Strategy & Corporate Development, Sobi
Duncan Young
Head of Search & Evaluation, Business Development, Oncology, AstraZeneca
Elizabeth Leshen
Head Search & Evaluation, Gene Therapy & Rare Disease, Novartis Pharma AG
Ena Prosser
Partner, Fountain Healthcare Partners
Hannah England
Partner, Ropes & Gray LLP
Hemant Sabherwal
Head of Corporate Solutions & EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
Jackie Iversen
Co-Founder & Chief Clinical Officer, Sen-Jam Pharmaceutical
Jasper Bos
General Partner, Forbion
Jasper Evers
Partner, Avance Life Sciences
Jay Campbell
Interim U.S. Site Head, Corporate Strategy & Development, Pilatus Biosciences SA
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
Joachim Vogt
Director Search & Evaluation International, AbbVie, Inc.
Jon Rees
CEO, MitoRx Therapeutics
Jyothis George
Chief Medical Officer, NodThera, Inc.
Karen Harris
CFO & Head of Mission Related Investments, Alzheimer's Drug Discovery Foundation
Klaus Dugi
CEO, Vandria SA
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Kristian Tryggvason
Founder & CEO, Alder Therapeutics AB
Lynn Durham
Founder & CEO, STALICLA SA
Maria Dahl
Executive Director, BD&L, Novartis Pharma AG
Marina Udier
CEO, Nouscom AG
Michael Altorfer
CEO, Swiss Biotech Association
Minyue Dong
Founder, Asian Innovation and Finance Center (AIFC)
Nate Chang
Operating Partner, Playground Global
Neil Goldsmith
Director & Strategy, BaseLaunch
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
Paul Bravetti
CEO, Brenus Pharma
Peter Louwagie
SVP Corporate & Business Development, Genmab A/S
Phil Masterson
Associate Director, Ventures, Cancer Research Horizons
Philip Larsen
CEO, SixPeaks Bio AG
Sabin Minguez
Senior Director, R&D Business Development, GSK
Sam Fazeli
Head of Research, Global Industries & Senior Pharmaceuticals Analyst, Bloomberg Intelligence
Seth Goldblum
SVP - Corporate Development, Cullgen Inc.
Simon Molgaard
Co-Founder & CEO, Teitur Trophics ApS
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Thibaut Roulon
Senior Investment Director, Bpifrance
Tugrul Ozdemir
Senior Associate, Seed Investments, Novo Holdings A/S
Winsome Cheung
Partner, Covington & Burling LLP
Yuehua Cong
CBO, HanchorBio Inc.
Yuwen Liu
Founding Partner, BOHE Angel Fund